Source:http://linkedlifedata.com/resource/pubmed/id/21750290
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2011-7-13
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
1538-3598
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
13
|
| pubmed:volume |
306
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
157; author reply 158-9
|
| pubmed:meshHeading |
pubmed-meshheading:21750290-Cardiovascular Diseases,
pubmed-meshheading:21750290-Diabetes Mellitus, Type 2,
pubmed-meshheading:21750290-Drug Utilization,
pubmed-meshheading:21750290-Dyslipidemias,
pubmed-meshheading:21750290-Fenofibrate,
pubmed-meshheading:21750290-Fibric Acids,
pubmed-meshheading:21750290-Humans,
pubmed-meshheading:21750290-Physician's Practice Patterns
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
Fibrate use in the United States and Canada.
|
| pubmed:publicationType |
Letter,
Comment
|